7th DIA Cardiac Safety Workshop in Japan

It will be a unique opportunity to learn of and discuss the current state and future directions of CV risk assessments and how to prepare for a new regulatory paradigm.

Back to Agenda

[Session 7] Abstract Session 2

Session Chair(s)

Yasunari Kanda, PhD

Head of Division of Pharmacology

National Institute of Health Sciences, Japan

Kaori Shinagawa, MD, PhD

Senior Scientist for Clinical Medicine, Office of New Drug II

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Speaker(s)

A Case of Spontaneous Smoking Echo in a Patient with Bladder and Pancreatic Cancer - Detection of Prothrombotic Status with Echocardiography

Takako Morooka

Nagoya University Hospital, Japan

Department of Medical Technique

Blood Pressure Monitoring in Clinical Trials - from Efficacy to Safety Endpoints - Design and Technology Considerations

Jeff Heilbraun, MS

Clario, United States

Vice President, Medical and Scientific Affairs, Cardiology

Have an account?